| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/02/2013 | CN101351199B Composition for soft contact lens and adsorption suppressing method |
| 01/02/2013 | CN101347459B Medicine for treating cancer |
| 01/02/2013 | CN101340911B Antitussive agent |
| 01/02/2013 | CN101316843B Aminopyrimidines useful as kinase inhibitors |
| 01/02/2013 | CN101296699B Pyrazolo[1,5-a]pyrimidine compounds |
| 01/02/2013 | CN101291950B Novel series of imidazolyl substituted steroidal and indan-1-one derivatives |
| 01/02/2013 | CN101287473B Agent for applying to mucosa and method for production thereof |
| 01/02/2013 | CN101277946B Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes |
| 01/02/2013 | CN101277739B Methods and compositions for improving cognitive function |
| 01/02/2013 | CN101273016B 抗菌喹啉衍生物 Antibacterial quinoline derivatives |
| 01/02/2013 | CN101267859B A pharmaceutical composition useful for the treatment of prostate cancer |
| 01/02/2013 | CN101247811B Quinoline derivatives as antibacterial agents |
| 01/02/2013 | CN101233145B Agent for amelioration of insulin resistance |
| 01/02/2013 | CN101229164B Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 01/02/2013 | CN101228149B Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors |
| 01/02/2013 | CN101189222B Tri-, tetra-substituted-3-aminopyrrolidine derivative |
| 01/02/2013 | CN101128196B Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases |
| 01/02/2013 | CN101119963B Methamphetamine derivatives and conjugates for immunoassay |
| 01/02/2013 | CN101102755B Use of renin inhibitors for the prevention or treatment of diastolic dysfunction or diastolic heart failure |
| 01/02/2013 | CN101087757B Novel dipeptidyl peptidase iv inhibitors, process for their preparation and compositions containing them |
| 01/02/2013 | CN101084195B 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 01/02/2013 | CN101068926B Multiple promoter expression cassettes for simultaneous delivery of RNAi agents |
| 01/02/2013 | CN101060835B Multiparticulate form of administration, comprising nucleic acid-containing mucoadhesive active ingredients, and method for producing the form of administration |
| 01/02/2013 | CN101035777B Modulators of hcv replication |
| 01/02/2013 | CN101035531B 卤代苯甲酰胺衍生物 Halogenated derivatives of benzamide |
| 01/02/2013 | CN101031338B Compositions and methods for treating cognitive disorders |
| 01/02/2013 | CN101011355B Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
| 01/01/2013 | US8344181 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 01/01/2013 | US8344177 Albumin binding molecules and uses thereof |
| 01/01/2013 | US8344160 Pyrrolone melanin concentrating hormone receptor-1 antagonists |
| 01/01/2013 | US8344155 Chemical compounds |
| 01/01/2013 | US8344153 Inhibitors of phosphatidylinositol 3-kinase |
| 01/01/2013 | US8344149 Crystalline form of benzothiophene compound and process for preparation thereof |
| 01/01/2013 | US8344146 Inhibitor of DD-peptidase and its use as antibiotic or anticancer drug |
| 01/01/2013 | US8344144 Inhibitors of Janus kinases |
| 01/01/2013 | US8344140 18F-labelled folates |
| 01/01/2013 | US8344138 Triazinedione derivatives as GABAB receptor modulators |
| 01/01/2013 | US8344133 Neoglycorandomization and digitoxin analogs |
| 01/01/2013 | US8344125 Modified iRNA agents |
| 01/01/2013 | US8344113 Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer |
| 01/01/2013 | US8344032 Composition for enhancing athletic performance |
| 01/01/2013 | US8344031 Compositions for the treatment of signs of aging |
| 01/01/2013 | US8344030 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine |
| 01/01/2013 | US8344029 Substituted propanamide derivative and pharmaceutical composition containing the same |
| 01/01/2013 | US8344028 Gamma-amino-butyric acid derivatives as GABAB receptor ligands |
| 01/01/2013 | US8344027 4-dimethylaminobutyric acid derivatives |
| 01/01/2013 | US8344026 Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents |
| 01/01/2013 | US8344025 Oxalic acid derivatives and use thereof as physiological cooling active ingredients |
| 01/01/2013 | US8344023 2,5-di- and 2,2,5-trisubstituted di- and tetrahydrofuran derivatives and their use for the production of perfumes |
| 01/01/2013 | US8344022 Vaginal health products |
| 01/01/2013 | US8344021 Administration of coumarin, butylated hydroxyanisole and ethoxyquine for the treatment of canities |
| 01/01/2013 | US8344020 Use of fusarochromanone and its derivatives in the diagnosis and treatment of cancer and other diseases |
| 01/01/2013 | US8344019 Methods for the production of biliverdin |
| 01/01/2013 | US8344018 Oxindolyl inhibitor compounds |
| 01/01/2013 | US8344017 Anti-hepatitis C virus agents and anti-HIV agents |
| 01/01/2013 | US8344016 Pyrazole derivatives as 11-beta-HSD1 inhibitors |
| 01/01/2013 | US8344015 2-alkyl-cycloalk(en)yl-carboxamides |
| 01/01/2013 | US8344014 Amino acid compositions |
| 01/01/2013 | US8344013 Dual-acting imidazole antihypertensive agents |
| 01/01/2013 | US8344012 Compounds, compositions and methods of using same for modulating uric acid levels |
| 01/01/2013 | US8344011 Compounds as opioid receptor modulators |
| 01/01/2013 | US8344010 Fused imidazole derivatives as TRPV3 antagonist |
| 01/01/2013 | US8344009 Substituted phenoxy thiazolidinediones as estrogen related receptor-á modulators |
| 01/01/2013 | US8344008 Aryl-substituted bridged or fused diamines as modulators of leukotriene A ydrolase |
| 01/01/2013 | US8344007 Water-soluble polymer-based cantharimides as potentially selective anti-tumor agents |
| 01/01/2013 | US8344006 Liquid formulations of bendamustine |
| 01/01/2013 | US8344005 5-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoMethylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2 as NK1 receptor antagonists |
| 01/01/2013 | US8344004 Cyclic pyridyl-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 01/01/2013 | US8344003 2-pyridinecarboxamide derivatives |
| 01/01/2013 | US8344002 Compound having β-secretase inhibitory activity |
| 01/01/2013 | US8344001 Heterocyclic H3 antagonists |
| 01/01/2013 | US8344000 Compounds which have activity at M1 receptor and their uses in medicine |
| 01/01/2013 | US8343999 Thiazolyl compounds useful as kinase inhibitors |
| 01/01/2013 | US8343998 Triazolothiadiazole inhibitor of c-Met protein kinase |
| 01/01/2013 | US8343997 Thiazolopyridine sirtuin modulating compounds |
| 01/01/2013 | US8343996 Azaquinolinone derivatives and uses thereof |
| 01/01/2013 | US8343995 Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use |
| 01/01/2013 | US8343994 Fluorene compound and pharmaceutical use thereof |
| 01/01/2013 | US8343993 Hydroxyalkyl substituted imidazonaphthyridines |
| 01/01/2013 | US8343992 Synthesis of R-N-methylnaltrexone |
| 01/01/2013 | US8343991 Anhydrous crystalline vinflunine salts, method of preparation and use thereof as a drug and means of vinflunine purification |
| 01/01/2013 | US8343990 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment |
| 01/01/2013 | US8343989 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor |
| 01/01/2013 | US8343988 Inhibitors of histone deacetylase |
| 01/01/2013 | US8343987 Heterocyclic derivatives |
| 01/01/2013 | US8343986 Matrix metalloproteinase inhibitors |
| 01/01/2013 | US8343985 Methods for modulating Lyn kinase activity and treating related disorders |
| 01/01/2013 | US8343984 Protein kinase inhibitor; purity; polymorphism |
| 01/01/2013 | US8343983 Substituted pyrazolo-pyrimidine compounds |
| 01/01/2013 | US8343982 Bicyclic heterocyclic compounds pharmaceutical compositions containing these compounds, their use and process for preparing the same |
| 01/01/2013 | US8343981 Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents |
| 01/01/2013 | US8343980 Quinazoles useful as modulators of ion channels |
| 01/01/2013 | US8343979 Use of alkanoyl L-carnitine for the treatment of erectile dysfunction |
| 01/01/2013 | US8343978 Fast onset orodispersable tablets |
| 01/01/2013 | US8343977 Substituted triazolo-pyrimidine compounds |
| 01/01/2013 | US8343976 Compounds, compositions and methods comprising pyrazole derivatives |
| 01/01/2013 | US8343975 4-amino-3-(imidazolyl)-pyrazolo[3,4-D]pyrimidines |
| 01/01/2013 | US8343974 Methods and compositions for treating thyroid-related medical conditions with reduced folates |
| 01/01/2013 | US8343973 Phenoxymethyl heterocyclic compounds |
| 01/01/2013 | US8343972 Organic compounds |